期刊
CLINICAL INFECTIOUS DISEASES
卷 60, 期 12, 页码 1860-1863出版社
OXFORD UNIV PRESS INC
DOI: 10.1093/cid/civ155
关键词
HIV/AIDS; tuberculosis; efavirenz; rifampin; pharmacogenetic
In STRIDE, slow metabolizer CYP2B6 and NAT2 genotypes were each associated with increased plasma efavirenz concentrations during antituberculosis therapy. Concentrations were greater on therapy than off therapy in 58% with CYP2B6 and 93% with NAT2 slow metabolizer genotypes. Individuals with slow metabolizer genotypes in both genes had markedly elevated concentrations.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据